MPS Powered by Eureka

Current Biotechnology

ISSN: 2211-5501 (Print)
eISSN: 2211-551X (Online)

Aims and Scope:Current Biotechnology publishes critical and authoritative reviews/mini-reviews, original research and methodology articles, and thematic issues in all areas of biotechnology, including basic and applied research. The journal serves as an advanced forum for innovative studies and major trends at the interface of technology, life sciences and biomedicine. Our aim is to provide a comprehensive and reliable source of information on the current advances and future perspectives in key themes of biotechnology.

Topics covered include:
  • Agricultural And Plant Biotechnology
  • Analytical Biotechnology
  • Biochemical Engineering
  • Bioinformatics
  • Biostatistics
  • Bioenergy
  • Bioethics
  • Biological Engineering
  • Biomarkers
  • Biomaterials And Bioproducts
  • Biomedical Engineering Related To Biotechnology
  • Biomining And Bioremediation
  • Bionanotechnology
  • Biopolymers
  • Biorobotics
  • Biosensors
  • Chemical Biotechnology
  • Environmental Biotechnology
  • Food Biotechnology
  • Healthcare Biotechnology
  • Imaging Technology And Large Scale Biology
  • Instrumentation
  • Industrial Biotechnology
  • Life Detection Technology
  • Medical Biotechnology
  • Metabolic Engineering
  • Microbial Biotechnology
  • Molecular Therapy
  • Omics Technologies: Genomics, Transcriptomics, Proteomics, And Metabolomics
  • Pharmaceutical Biotechnology
  • Regenerative Medicine
  • Space Biotechnology
  • Synthetic Biology
  • Systems Biology
  • Tissue And Cell Engineering

Editor-in-Chief:


Paul Dalby United Kingdom

Indexed in:


Cabell's Directory/Journalytics, Cabell's Directory/Journalytics, Cabell's Directory/Journalytics... View all

Special Issues With Active Call for Papers

Submission closes on: Dec 31, 2025
Age Reversal using transient epigenetc reprogramming with the OSK Yamanaka Factors

Aging is a complex biological process characterized by a gradual deterioration of physiological functions and an increased vulnerability to disease. Recent advancements in the field of regenerative medicine have shown promising avenues for combating aging. Among these, partial epigenetic reprogramming, specifically utilizing the Yamanaka factors, has been shown to reverse the aging muti-omic processes in human tissue and experimental animal models. This special issue of Current Biotechnology explores the underpinnings and potential implications of employing... see more

Submission closes on: Dec 31, 2025
Leveraging AI for personalized pediatric neurodevelopmental support

Personalized medicine in pediatrics is a moving target dedicated to finding the right treatment, at the right time, for each individual child in each stage of development. Child development is a highly personal process, unique to each individual, something which is even more apparent in the development of children with neurodevelopmental conditions. These conditions have highly complex causalities involving genetics, biology and environmental factors. Personalized medicine can be used to find the causes of conditions,... see more

Submission closes on: Dec 31, 2025
Feeding a vegan World

The Eat-Lancet Planetary diet recommends at least 2/3 plant and microbial sources in the food protein portion. Such diet is recommended against obesity, cancer and to limit global warming, and might get more and more incentives in the next years. We thus need massive amounts of Plant-based food, and the general public might better accept processed foods, burgers or sausages than plain beans. Plant-based proteins are already available in the supermarkets, but meet some limits,... see more

Submission closes on: Dec 31, 2025
Nucleic acid-based therapeutics

The advent of nucleic acid therapeutics is well established and in the past decade several novel approaches have been developed to broaden the scope and utility of nucleic acid therapies. Current tools used for translational nucleic acid therapeutics include antisense oligonucleotides, siRNA, mRNA, self-amplifying RNA, lipid nanoparticles and adeno-associated viral vectors. However, their success relies on the ability of the approach being delivered stably in the clinical setting with minimal side effects. Recent improvements in... see more

Submission closes on: Dec 31, 2025
Bioinformatic Analysis of Regulated Cell Death in Chronic and Acute Inflammatory Diseases

In the intricate realm of inflammatory diseases, delving into the complexities surrounding regulated cell death emerges as an indispensable and forefront area of exploration. Understanding the intricacies of how cells are regulated to undergo death in inflammatory conditions not only represents a pivotal frontier in biomedical research but also holds profound implications for deciphering the underlying mechanisms driving disease pathogenesis and for devising targeted therapeutic interventions. This special issue endeavors to harness the potential of... see more

Submission closes on: Jul 10, 2025
Next-Generation Biofertilizers for Agricultural Sustainability

The use of biofertilizers is emerging as a crucial alternative to typical agrochemicals, enhancing crop productivity while reducing environmental impact. Biofertilizers promote soil health fostering beneficial microbial activity and plant development by improving nutrient availability of different elements like nitrogen or phosphorus. Furthermore, these beneficial microorganisms enhance plants' resistance to both biotic and abiotic stresses, protecting our crops from the climate change we have been experiencing in recent years. Biofertilizers, derived from natural sources such... see more